GeoPharma Posts Record Revenues for FY04

GeoPharma Posts Record Revenues for FY04

LARGO, Fla.GeoPharma Inc.(NYSE:GORX) announced record consolidated revenues of approximately $22.9million for the fiscal year ended March 31, 2004 (FY04), in contrast toapproximately $14.7 million for fiscal year 2003 (FY03).

Current fiscal year operations resulted in pretax net incomeof $1.3 million with net income available to common shareholders ofapproximately $1 million or $0.13 per basic share and $0.11 per fully dilutedshare for FY04 as compared to pretax net income of approximately $883,000 andnet income available to common shareholders of approximately $1.03 million or$0.15 per basic and fully diluted share for FY03. Cash earnings per share forthe fiscal year ended March 31, 2004, was $0.26 per basic share and $0.22 perfully diluted share, representing net income available to common shareholders asadjusted for non-cash charges related to deferred income tax, compensationexpense for warrants, stock and stock option grants, and depreciation andamortization.